DERMATA THERAPEUTICS, INC. Earnings Per Share (Basic)
DERMATA THERAPEUTICS, INC. (DRMA) reported Earnings Per Share (Basic) of -$0.74 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- DERMATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.74.
- DERMATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.48.
- DERMATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.65.
- DERMATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$1.22.
- DERMATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$8.16.
- DERMATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$80.32.
- DERMATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$39.99.
- DERMATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$13.92.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.74 10-Q · filed 2026-08-11 | -$1.66 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | -$0.48 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | -$8.16 10-K · filed 2026-03-26 | |||||
| 2025-09-30 | -$1.65 10-Q · filed 2025-11-14 | -$6.64 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | -$1.22 10-Q · filed 2026-08-11 | -$1.66 10-Q · filed 2025-08-13 | -$5.18 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | -$4.47 10-Q · filed 2026-05-13 | -$0.45 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | -$80.32 10-K · filed 2026-03-26 | -$8.03 10-K · filed 2025-03-17 | ||||
| 2024-09-30 | -$20.41 10-Q · filed 2025-11-14 | -$102.18 10-Q · filed 2025-11-14 | ||||
| 2024-06-30 | -$41.82 10-Q · filed 2025-08-13 | -$106.44 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | -$7.06 10-Q · filed 2025-05-14 | |||||
| 2023-12-31 | -$39.99 10-K · filed 2025-03-17 | -$2.67 10-K · filed 2024-03-21 | ||||
| 2023-09-30 | -$0.54 10-Q · filed 2023-11-09 | -$2.46 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$0.63 10-Q · filed 2023-08-10 | -$2.13 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | -$2.27 10-Q · filed 2023-05-11 | |||||
| 2022-12-31 | -$13.92 10-K · filed 2024-03-21 | -$0.87 10-K · filed 2023-02-21 | ||||
| 2022-09-30 | -$3.16 10-Q · filed 2023-11-09 | -$11.96 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -$3.90 10-Q · filed 2023-08-10 | -$9.02 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$0.33 10-Q · filed 2022-05-16 | |||||
| 2021-12-31 | -$2.43 10-K · filed 2023-02-21 | |||||
| 2021-03-31 | -$1.21 10-Q · filed 2022-05-16 | |||||
| 2020-12-31 | -$1.69 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |